Sale, M. J., Minihane, E., Monks, N. R., Gilley, R., Richards, F. M., Schifferli, K. P., . . . Cook, S. J. (2019). Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors. Nature Portfolio.
Chicago Style (17th ed.) CitationSale, Matthew J., et al. Targeting Melanoma’s MCL1 Bias Unleashes the Apoptotic Potential of BRAF and ERK1/2 Pathway Inhibitors. Nature Portfolio, 2019.
MLA (8th ed.) CitationSale, Matthew J., et al. Targeting Melanoma’s MCL1 Bias Unleashes the Apoptotic Potential of BRAF and ERK1/2 Pathway Inhibitors. Nature Portfolio, 2019.
Warning: These citations may not always be 100% accurate.